In this article, we show how to investigate the role of individual (personal) risk factors on outcome prevalence in multicentre studies with multilevel modelling. The variation in outcome prevalence is modelled by introducing a random intercept. In the next step, the empty model is compared with the model containing the risk factor(s). Because the outcome is dichotomous, this comparison can only carried out after having rescaled the models' parameter values to the variance of an underlying continuous variable. We illustrate this approach with data from Phase Two of the International Study of Asthma and Allergies in Childhood (ISAAC) and provide a corresponding Stata do-file.
Introduction:
Many diseases vary widely in prevalence worldwide and a most plausible explanation is the influence of environmental risk factors. Environmental risk factors vary also widely in prevalence over the world and often provide exposure contrasts between populations where within population contrasts are low 1 . Investigation of differences between diverse populations has given important insights for instance regarding cardiovascular risk factors 2 and asthma and allergies in children 3 .
However, simple ecological comparisons, using aggregated data only, do not take into account associations at the individual level and are potentially prone to ecological fallacies. A multilevel approach can take into account the contribution of individual risk factors on disease prevalence in different locations (e.g. countries), thus shedding light on potential ecological fallacies.
The more usual focus on the association between disease and risk factors within populations ignores the broader issue of the importance of these factors in determining the burden of disease in whole populations and therefore the potential for prevention at a community level.
The multilevel approach can be used to investigate both the variation between locations and the determinants of this variation. These will be risk factors that have an association with the disease at the individual level but also vary in their prevalence between locations or study centres.
Although the multilevel framework has the potential of investigating both the individual and population level determinants of disease variation it seems to have been used very little in epidemiology. So far studies investigating the differences between locations come rather from the social sciences such as the classic example by Lee & Bryk on mathematics achievement in different schools 4 or newer work e.g. investigating children's wellbeing using indicators 5 . In the health sector, Wainwright & Surtees 6 give an example of analysing functional health scores.
In these cases the outcome investigated is generally continuous and linear multilevel or "hierarchical linear models" can be used. In such models the total variance can be easily decomposed in three variance components: 1) the explained variance that can be attributed by variation in a predictor variable (e.g. risk factor), 2) the unexplained variance (or residual variance) at the individual level and 3) the unexplained variance at the centre level. The latter is equivalent to the variation of the random intercept. The advantage of linear models is that models with different number of risk factors can be easily compared regarding the change of their parameters and therefore also of the variation between locations. Hence these models allow a direct assessment of the change in variation when a risk factor is introduced into the model.
In epidemiology, however, outcomes are very frequently binary and the corresponding multilevel logistic regression models do not allow such a simple comparison between models, although this sometimes seems to have been ignored (for example [7] [8] [9] ). For a binary variable, the residual variance at the individual level is determined by the binomial distribution and has a fixed value of  Bauer 11 proposed a scaling procedure to achieve comparable estimates between different probit or logistic regression models, based on the assumption of an underlying continuously distributed variable. , we apply, to our knowledge for the first time, bootstrap methods to estimate the related confidence intervals.
In summary, without a scaling procedure it is not possible to quantify the variance in the random intercept that reflects the prevalence variation of any binary outcome, and therefore not possible to assess the influence of any risk factor on this prevalence variation. Therefore, in this tutorial we show how to apply this approach to the investigation of variation in disease prevalence across locations using the data of the Phase Two of the International Study of The use of multilevel models for modelling prevalence variation In an ordinary one-level regression model the assumption is that all individuals, even if from different centres, belong to one common population. In a multi-level model, we consider that there may be genuine differences between centre populations, which are themselves a sample from a superpopulation. The corresponding variation in the outcome is accounted for by the random intercept in the multilevel model and therefore is equivalent to modelling the prevalence of centres -indeed in logistic regression the intercepts are the centre-level prevalence logodds.
To model the random intercept, we introduce a random effect term at the centre level (level 2 . This variance is equivalent to the variance between centres in the random intercept and therefore to the variance around the grand mean of the prevalence logodds (γ00 ) as reflected in the full dataset.
Here we deal with models where the centres have the same slope (representing a fixed effect of the risk factor on disease logodds) and vary only in the intercept (Figure 1 ). Thus,
we use a multilevel model with a random intercept i.e. there is only a second level variation term (error term) for the intercept. Multilevel models can also incorporate random variation of the slope which, however, is beyond the scope of the current article. Introduction of random slopes poses additional problems of analysis and interpretation of the distribution of random intercepts, because the variance of these intercepts will vary according to the choice of origin (zero exposure) for the explanatory variables with non-fixed slopes.
As in other regression models explanatory variables can be introduced which will lead to a change in the variance explained by the model. In the specific case of a model with a random intercept but fixed slopes, his general formula reduces to Note that a and are identical, e.g. for logistic regression, or 1 for a probit regression.
Thus conceptually the scaling factor is the ratio of the individual-level residual (binomial sampling) variance ( for logistic regression) to the sum of the variance explained at the individual level ( ∑ ), the unexplained centre-level variation ( tau 2 ) and the unexplained (sampling) variation at the individual level ( for logistic regression).
In the case of a model without risk factors, the formula for the scaling factor reduces further to = / ( + ) (eq. 2).
Only parameters rescaled with this scaling factor can be compared directly between models.
Therefore, this scaling procedure is necessary when assessing the reduction in between-centre variance after introducing an individual-level risk factor. Note that the scaling factor for the effect estimates ( ) is the square root of the above scaling factor for the variance.
Introduction into the worked example: The ISAAC Phase Two data set
The data set used in this example comes from the Phase Two of ISAAC which is a multicentre cross-sectional study that was carried out in 30 centres in 21 countries and investigated children on average 9-11 years old 15 . Outcome data derive from standardized questionnaires on symptoms of asthma and from the results of skin prick tests to six aeroallergens 16 .
The main symptom of asthma used in analysis is "wheeze in the past year" which is a binary variable "yes"-"no". A skin prick test was rated as positive if the wheal size in response to any of the six allergens was greater than 3 mm, after subtraction of the negative control. The variables from the risk factor questionnaire we use in this example are mostly dichotomous, but also categorical or continuous variables may be introduced into the model. All questionnaires were filled in by the care taker, usually parents. The detailed questionnaires are available on http://isaac.auckland.ac.nz/phases/phasetwo/phasetwomodules.pdf.
In this article we use a subset of centres that had investigated risk factors in the full sample (as opposed to a subsample stratified by wheeze) and information on the respective risk factor and outcome. Only children with information on the risk factors used in the examples are included in these restricted data sets: 27 719 children from 24 centres contribute to the example examining skin prick test positivity and number of siblings, and 34 809 children from 24 centres and contribute to the example investigating wheeze and four selected risk factors.
These four selected risk factors were: Mother smoked during the first year of life of the child (yes/no), the child has had a whooping cough infection (yes/no), the child had been breastfed (yes/no) and fish consumption at least once a week (yes/no).
Examples of analyses on the Phase Two data
We explore two examples, the numbers of siblings in relation to atopy and the influence of four risk factors on asthma. The number of siblings has been shown to be an important factor influencing the occurrence of allergic disease 17 and we chose therefore to investigate its relation with an objective marker of allergy i.e. skin prick test positivity. The number of siblings is furthermore very variable in the international context with higher mean numbers in less affluent centres. On theoretical grounds we would expect an individual risk factor that has a) a reasonable strong effect size and b) a high variability between populations to have a notable effect on prevalence differences worldwide.
After a first exploration of the Phase Two data sets we chose the risk factors for our wheeze example to reflect different directions of association (harmful and protective) on the individual level and the ecological level. On the individual level, maternal smoking and whooping cough infection represent harmful factor and breastfeeding and fish consumption the protective factors. On the ecological level, maternal smoking and breastfeeding have positive correlation with wheeze prevalence, whereas whooping cough infection and fish consumption have a negative correlation. As we will see both the individual and ecological level matter for the direction of the overall change in variation, highlighting that ecological analyses on their own may be misleading in this kind of analysis. The prevalence of all four risk factors varies strongly in the international context.
a) Example 1: number of siblings and atopy
In a first example we consider how much of the international variation in the prevalence of atopy, defined as a positive skin prick test, can be explained by the reported number of siblings and birth order as reflected by the number of older siblings.
To evaluate the change in the rescaled tau 2 when introducing an explanatory variable, we first calculate an empty model without the risk factor to determine the variation in wheeze prevalence as reflected by tau 2 which is 0.6061. This entity, we call tau0 2 .
We use eq. 2 to calculate the scaling factor. In our case of a logistic regression model for a binary outcome, a and in the equation are . We obtain a scaling factor of 0.844 and therefore a rescaled tau0 2 of 0.5115.
We then introduce the number of siblings (variable num_sibs) into the model (see Figure 2) and obtain a tau 2 of 0.5657 which is (0. 7521 2 ) i.e. the sd(_cons) from Figure 2 squared.
For the formula we now need to calculate the term ∑ (see eq.1).
b, the vector of the regression coefficients, starting with the intercept, is here (-1.296155 -0.0542936) see Figure 2 , and therefore its transpose is . .
. Note that the order of the regression coefficients in Stata is actually in the inverse order of that needed in the formula (e.g. intercept in the last instead of the first position).
∑ , is obtained in Stata with "correlate num_sibs, cov" and contains the covariance matrix, in the single risk factor case simply the variance of that variable (3.19307) , and is then enhanced with additional 0s to obtain
The whole formula for the scaling factor according to (eq. 1) therefore is We next introduce a second variable, the number of older siblings (oldersibs) into the model.
As we have already the number of all siblings in the model, this variable reflects mainly birth order and informs us whether having older sibling has a stronger effect than having younger siblings.
b, the vector of the regression coefficients, starting with the intercept followed by the first and then the second explanatory variable, is now (-1.295132 -0.0576607 0.005064) see Figure   3 , and therefore its transpose is . . . The whole formula for the scaling factor according to (eq. 1) therefore is This is very similar to the figure of 5.91% obtained from the single risk-factor model with total number of siblings. This reflects both the weakness of the older siblings effect at the individual level, independent of total siblings, and the fact that mean birth order does not vary greatly between study centres independently of total sibship size, whereas there is much greater variation in total sibship size.
b) Example 2: Influence of several risk factors on wheeze in the past year
In the second example we investigate several risk factors for their influence on the variation of wheeze prevalence.
We start by investigating each risk factor separately for the change in tau after this risk factor has been introduced into the random intercept model without any explanatory variables ("empty model"). We then start building a multivariate model introducing the explanatory factors one-by-one. The variable "mother smoking in the first year of life of the child" has a moderate association with wheeze at the individual level with an odds ratio (OR) of 1.2 which is statistically significant. This risk factor is also quite variable in its prevalence across the centres ( Table   1 ). The introduction of this risk factor results in a relative reduction in the variability between centres, as reflected by tau 2 , of 7.1%. This risk factor has a positive ecological correlation with wheeze and hence the tau 2 is decreased.
Whooping cough has a moderately higher and also statistically significant effect size and a somewhat lower variation in prevalence between centres. However, this factor entrains an increase in tau. This seems at first glance counterintuitive because one might think that introduction of any predictive factor will decrease the variance. The increase in tau 2 is a consequence of the negative ecological correlation between the wheeze prevalence and the whooping cough infection prevalence -in contrast to the prevalence of mothers smoking where we had a positive correlation with wheeze prevalence at the centre level ( Figure 5 )
We also observe an increase in tau 2 for breastfeeding, where the ecological correlation is positive but the association at individual level is inverse i.e. smaller than one. On the other hand, for fish consumption, where both the odds ratio as well as the correlation are negative we observe again a decrease in tau 2 .
The final model (Table 2) , incorporating individual level variables that decrease and increase the tau 2 results in an overall decrease of 1.8%.
The precision of our estimates of the change in tau 2 , is not obtainable directly from model outputs, so we have applied bootstrapping to determine its 95%-confidence interval (CI). As we are looking at a centre-level parameter, bootstrapping should not sample individual children but needs to sample centres, i.e. a block sampling procedure has to be performed.
Performing this procedure 2000 times is sufficient to derive 95% CI 18 . For carrying out the block sampling procedure in our worked example, complete centres were randomly selected with replacement from the whole study population until the number of centres reached 24 in each bootstrap sample. Because of different numbers of children in each centre, the number of children varied between the bootstrap samples. The empty model and the full model were fitted to each bootstrap sample and afterwards the results were rescaled. A simple 95% bootstrap confidence interval was obtained using the 2.5% and the 97.5% percentile as confidence limits. For the example with skin prick test and siblings, we obtain thus a relative reduction of unexplained between-centre variance of 6% with the CI ranging from -0.5% to 14%. For the wheeze example with its small decrease of unexplained between-centre variance of 1.8% we obtain a CI of -7% to 8.8%.
In the appendix we present the code of a Stata macro that runs the multilevel analyses and calculation for models with as many risk factors as desired. This procedure can easily be adapted to probit regression (as used by Bauer 11 ) by replacing π 2 /3 by 1. In our data set, the results and scaling factors obtained by probit regression were very similar to the results obtained by logistic regression.
Our Stata-Macro can be adapted to accommodate sampling weights which are necessary often in survey data or when analysing stratified subsamples (see code in the appendix). For example, the ISAAC Phase Two data consists partly of subsamples stratified by wheeze i.e. 100 wheezers and non-wheezers were sampled in some centres for certain modules 15 . In this case, we use gllamm to incorporate the appropriate "pweight". Note, however that certain conditions have to apply to get reliable unbiased results from this weighted multilevel approach using a so-called pseudolikelihood. For details we refer the reader to RabeHesketh & Skrondal 19 and Rabe-Hesketh & Skrondal 20 on page 572. Note also that stratum sampling weights remain necessary even if the outcome variable is the one that was used to define the stratified subsample. This is in contrast to the more conventional analyses of the effects of risk factors on the outcome itself, where no weighting is needed because the analyses then correspond to a classical case-control analysis. However in our analysis, we are interested in the intercept and its variation and not in the effect estimates. Therefore not weighting the children in the subsample to the frequencies in the full sample will result in falsely elevated intercepts in the centres concerned -just as we cannot interpret the intercept as baseline prevalence in a case-control study. The consequence is a grossly false result for the overall intercept and its variation tau 
General Discussion
Our application of Bauer's method 11 . Other studies on diverse outcomes found an even lower tau 2 8,22,23 . We are not aware of any study reporting corresponding figures for a binary outcome in an international multi-centre study.
Our modelling with real world data showed that the incorporation of individual level variables, in contrast to centre level variables, can either decrease or increase the unexplained between-centre variance (tau The scaling factors we observe in our data set vary little between models and are closer to one than the ones from the example of simulated data in Bauer
11
. In general, we expect the scaling factor to deviate more strongly from one when the unexplained between-centre variance tau 2 and/or the explained variance ∑ are high. The scaling factor will differ between models when the explained variance at individual level differs markedly between the models and/or tau 2 increases: in the case of explained variance at the individual level, an increase in the explained variance will be important because there is no concomitant decrease in tau 2 . Note that when adding centre level variables, no rescaling is necessary as these variables cannot explain any of the individual level variation. Thus changes in scaling factors between models will be minute and within the range of imprecision resulting from model estimation.
One limitation of our presented approach is that we have assumed a fixed slope for the individual level variables which is equivalent to assuming the same relationship between influence factors and outcome in all centres. From a methodological point of view, Bauer's method 11 can also accommodate random slopes. The interpretation becomes less straightforward in this case, as the variance of the intercept will depend on the value of the covariate with the random slope and hence the parametrization of that covariate has to be chosen with care. Also, the mere fact of including a covariate will most likely increase the imprecision around the estimated tau . The results for the comparison with the null model obtained by meresc and our Stata-macro are very similar and differ only in the 4 th last decimal. This is due to the fact that the procedure to determine the explained variance is slightly different: meresc uses the variance of the predicted values whereas Bauer's formula uses the covariance matrix in combination with the regression coefficients. The equivalence of both approaches to the explained variance is given in Bauer's article 11 in formula (22) . The approach in meresc corresponds to the binary case of the method of Fielding 12 presented for outcomes with several categories. Note that meresc does not run after gllamm.
In conclusion, our approach allows extending the investigation of the influence of personal risk factors on the variation of a continuous outcome between populations to binary outcomes. This is a useful exercise when trying to identify new risk factors especially when they may show little variation in a given location. This method also provides a quantitative insight of the extent to which elimination of a given risk factor would reduce international differences in prevalence. A Stata code is given to implement this kind of analyses.
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Key messages
Investigating differences in prevalence between centres in a multicentre study, in particular in an international setting, can give important insights regarding relevant risk factors By quantifying the variation of the random intercept in a multicentre study it can be estimated how much of variation in the outcome prevalence can be attributed to ecological and individual level risk factors
In the case of a binary outcome, e.g. for multilevel logistic regression, a scaling procedure has to be performed to allow the direct comparison between models with different individual level risk factors ; § the prevalence is calculated as natural logarithm of the intercept;
$ the odds ratios are given for the final model Appendix: Stata macro code * Stata program to rescale estimates obtained from 2-level models (1st level: individuals 2nd level: study centres) * calculated in xtlogit * rescaling formulae from Bauer 2008 * originally programmed in STATA10, later also used in STATA14 *************************************************************************** ********************************************** use "G:\Daten1\ISAACII.dta", clear cd "G:\Gudrun\ISAACII\Tutorial\" global logfile="logfilename.log" log using "$logfile", replace count set more off *************************************************************************** ****************************************** ****** regression model for the Null Model (with random intercept for study centre but without any risk factor) *********************** ** example: skin prick test positivity = sp09x xtlogit sp09x, i(centre) quad(30) matrix u0=e(b) * tau (NOT tau2) contained in e(sigma_u) * e(b) contains the individual-level parameters plus lntau (not tau2) as the last element * We can't access element of e(b) directly without copying e(b) to another matrix matrix u0=e(b) scalar tau02=e(sigma_u)^2 **** corresponding gllamm syntax********** ** run gllamm twice to speed up estimation, statements nip(5) and then nip(30) important to get correct estimates! gllamm sp09xx, i(centre) link(logit) family(bino) nip (5) pweight(wt) matrix b0= e(b) gllamm sp09xx, i(centre) link(logit) family(bino) nip(30) pweight(wt) from (b0)adapt matrix u0=e(b) scalar tau02=u0 [1, 2] ^2 ****************************************** **** calculate the scaling factor and rescaled tau2 from Bauer, 2008 * calculating null model implied total variance of latent variable y matrix y0 = tau02 + c(pi)^2/3 mat list y0 * computing the scaling factor(s) to convert to marginally standardized estimates scalar scaling_factor_tau02=(c(pi)^2/3)/(y0 [1, 1] ) scalar rescaled_tau2_null_model = tau02*(c(pi)^2/3)/(y0 [1, 1] ) scalar list *************************************************************************** ****************************************** *************** regression model with risk factor(s) *********************************************** * define risk factor sets to be run global rf_1 "rf06_04xx" global rf_2 "rf05_04xx" global rf_3 "rf05_04xx rf06_04xx" global riskfactor_list " "$rf_1" "$rf_2" "$rf_3" " * set up temporary file as required by postfile command tempname testoutfile foreach rf of global riskfactor_list { * specify variable types and names you want to have in the output file and name of the output file postfile`testoutfile' str100 (riskfactor) float (Nchild Ncentres Tau2 rescTau2 reduction_Tau2 reduction_rescTau2 Relreduction_Tau2 Relreduction_rescTau2 estimate stderr) using "`rf'.dta", replace ******************* regression model with risk factor(s) *********************************** xtlogit sp09xx`rf', i(centre) quad(30) matrix u=e(b) matrix v=e(V) ** extract tau2 and its standard error scalar tau2=e(sigma_u)^2 scalar list tau2 **** corresponding gllamm syntax********** ** run gllamm twice to speed up estimation, statements nip(5) and then nip(30) important to get correct estimates! gllamm sp09xx`rf', i(centre) link(logit) family(bino) nip (5) pweight(wt) matrix b= e(b) gllamm sp09xx`rf', i(centre) link(logit) family(bino) nip(30) pweight(wt) from (b)adapt matrix u=e(b) matrix v=e(V) ** extract tau2 and its standard error scalar tau2=M_cov [1, 1] scalar list tau2 ****************************************** *** Creating covariance matrix required for scaling formula ******************************** ** = create "cra", the covariance matrix with additional 0-cells needed in the formula correlate`rf' if wh02x != ., cov matrix a=r(C) *define cn=colsof (a) 
